The Latest Cardiac and Vascular News
Study Intends to Demonstrate that Ultrasound Allows for Precise Deployment and Positive Positioning of the MANTA® Vascular Closure Device WAYNE, Pa., June 22, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced […]
WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA® Vascular Closure Device – the first commercially available biomechanical vascular […]
WAYNE, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) today announced the publication of the “Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.” The SAFE MANTA IDE Clinical Trial, […]
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies with solutions in the fields of vascular and interventional access, surgical and cardiac care, will showcase the MANTA™ Vascular Closure Device as well as its portfolio for […]
MALVERN, Pennsylvania, June 18, 2018 /PRNewswire/ — Essential Medical, Inc., a private medical device company focused on innovative solutions for large bore vascular closure, today announced that the results from the SAFE MANTA IDE clinical trial will be presented at the Transcatheter Valve Therapies (TVT) […]
